Paul Saladino· MD
𝐏𝐨𝐨𝐫𝐥𝐲 𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐜𝐭𝐞𝐝 𝐭𝐫𝐢𝐚𝐥. 𝐍𝐨𝐭 𝐚 𝐯𝐚𝐥𝐢𝐝 𝐒𝐅 𝐯𝐬 𝐎𝐦𝐞𝐠𝐚-𝟔 𝐜𝐨𝐦𝐩𝐚𝐫𝐢𝐬𝐨𝐧 𝐝𝐮𝐞 𝐭𝐨 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐓𝐅 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐧𝐭𝐫𝐨𝐥 𝐠𝐫𝐨𝐮𝐩 𝐚𝐧𝐝 𝐦𝐢𝐱𝐞𝐝 𝐎-3/𝐎-6 𝐢𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
𝐏𝐨𝐨𝐫𝐥𝐲 𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐜𝐭𝐞𝐝 𝐭𝐫𝐢𝐚𝐥. 𝐍𝐨𝐭 𝐚 𝐯𝐚𝐥𝐢𝐝 𝐒𝐅 𝐯𝐬 𝐎𝐦𝐞𝐠𝐚-𝟔 𝐜𝐨𝐦𝐩𝐚𝐫𝐢𝐬𝐨𝐧 𝐝𝐮𝐞 𝐭𝐨 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐓𝐅 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐧𝐭𝐫𝐨𝐥 𝐠𝐫𝐨𝐮𝐩 𝐚𝐧𝐝 𝐦𝐢𝐱𝐞𝐝 𝐎-3/𝐎-6 𝐢𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.